FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 …
Read More